American Society For Experimental Neurotherapeutics Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2019 | 320,803 | 343,354 | −22,551 | 12.2 | 39% |
| 2020 | 313,990 | 375,701 | −61,711 | 9.2 | 41% |
| 2021 | 287,384 | 254,116 | 33,268 | 15.2 | 28% |
| 2022 | 236,991 | 430,354 | −193,363 | 3.6 | 18% |
| 2023 | 508,582 | 393,047 | 115,535 | 7.8 | 21% |
In its most recent public year (2023), this organization brought in $115,535 more than it spent. Its reserves stood at about 7.8 months of spending, down from 12.2 in 2019. Staff pay was 21% of spending. $209,184 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works